Work

The Myocyte Enhancer Factor 2C (MEF2C) Is a Direct Transcriptional Target of HOXA9 and Mediates Leukemia Survival in Human Mixed-Lineage Leukemias.

Year: 2007

Type: article

Source: Blood

DOI: 10.1182/blood.v110.11.58.58

Authors: Jorg Faber, Andrei V. Krivstov, Matthew C. Stubbs, Marry van den Heuvel-Eibrink, Andrew L. Kung, Christian M. Zwaan, Scott A. Armstrong

Institutions: Boston Children's Hospital, Erasmus MC - Sophia Children’s Hospital, Harvard University, Dana-Farber Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590205190

FWCI: 0.212

Cites:

Cited by: 1

Related to: 10